Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents

1 Jan 2010

Abstract excerpt

We studied whether MF59-adjuvanted influenza vaccine improves immunity against drifted influenza strains in institutionalised elderly with underling chronic health conditions. Sera from a randomized study, comparing MF59-adjuvanted (Sub/MF59, n = 72), virosomal (SVV, n = 39), and split (n = 88) vaccines, were retested using a hemagglutination inhibition (HI) assay against homologous (Northern Hemisphere [NH]...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Respiratory viral infections research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20369059
DOI: 10.1155/2010/517198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly ResidentsPMID 20369059Read ↗

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.Semantic proximity Read ↗

A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and olderSemantic proximity Read ↗

A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the ElderlySemantic proximity Read ↗

Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled TrialSemantic proximity Read ↗

Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysisSemantic proximity Read ↗

Influenza vaccine-specific T cell responses are impaired in older adultsSemantic proximity Read ↗

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.Semantic proximity Read ↗

Quadrivalent adjuvanted haemagglutinin nanoparticle influenza vaccine: a step towards better protection of older adults from the constantly mutating H3N2 influenza viruses.Semantic proximity Read ↗

Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents.Semantic proximity Read ↗

Neuraminidase Antibody Response to Homologous and Drift Influenza a Viruses After Immunization with Seasonal Influenza VaccinesSemantic proximity Read ↗

[Evaluation of vaccination for geriatric patients].Semantic proximity Read ↗

A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in AdultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.